Simplex Trading’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $237K | Sell |
139,995
-33,070
| -19% | -$68.1K | ﹤0.01% | 4095 |
|
|
2025
Q4 | $343K | Buy |
173,065
+11,387
| +7% | +$36.5K | ﹤0.01% | 3688 |
|
|
2025
Q3 | $470K | Buy |
161,678
+144,417
| +837% | +$332K | ﹤0.01% | 3910 |
|
|
2025
Q2 | $31K | Buy |
17,261
+7,317
| +74% | +$13K | ﹤0.01% | 6377 |
|
|
2025
Q1 | $14K | Sell |
9,944
-50,977
| -84% | -$129K | ﹤0.01% | 6859 |
|
|
2024
Q4 | $143K | Buy |
+60,921
| New | +$1.07M | ﹤0.01% | 4843 |
|
|
2024
Q3 | – | Sell |
-28,235
| Closed | -$650K | – | 9445 |
|
|
2024
Q2 | $348K | Buy |
28,235
+18,297
| +184% | +$386K | ﹤0.01% | 4058 |
|
|
2024
Q1 | $201K | Buy |
9,938
+9,085
| +1,065% | +$209K | ﹤0.01% | 4864 |
|
|
2023
Q4 | $19K | Buy |
+853
| New | +$18K | ﹤0.01% | 6970 |
|
|
2023
Q3 | – | Sell |
-38,751
| Closed | -$768K | – | 9678 |
|
|
2023
Q2 | $950K | Buy |
38,751
+34,351
| +781% | +$827K | ﹤0.01% | 2649 |
|
|
2023
Q1 | $106K | Buy |
+4,400
| New | +$122K | ﹤0.01% | 5095 |
|
|
2022
Q4 | – | Sell |
-2,422
| Closed | -$87K | – | 10257 |
|
|
2022
Q3 | $101K | Sell |
2,422
-10,854
| -82% | -$293K | ﹤0.01% | 5516 |
|
|
2022
Q2 | $373K | Buy |
13,276
+7,235
| +120% | +$183K | ﹤0.01% | 3826 |
|
|
2022
Q1 | $224K | Buy |
6,041
+5,789
| +2,297% | +$245K | ﹤0.01% | 4995 |
|
|
2021
Q4 | $11K | Sell |
252
-56,630
| -100% | -$2.97M | ﹤0.01% | 8956 |
|
|
2021
Q3 | $5.05M | Buy |
56,882
+7,414
| +15% | +$619K | ﹤0.01% | 1204 |
|
|
2021
Q2 | $4.23M | Buy |
49,468
+41,855
| +550% | +$2.24M | ﹤0.01% | 1337 |
|
|
2021
Q1 | $342K | Sell |
7,613
-25,785
| -77% | -$1.01M | ﹤0.01% | 3966 |
|
|
2020
Q4 | $0 | Buy |
33,398
+10,048
| +43% | +$89.7K | ﹤0.01% | 8980 |
|
|
2020
Q3 | $0 | Buy |
23,350
+23,140
| +11,019% | +$104K | ﹤0.01% | 8415 |
|
|
2020
Q2 | $0 | Sell |
210
-39,861
| -99% | -$181K | ﹤0.01% | 8265 |
|
|
2020
Q1 | $164K | Buy |
+40,071
| New | +$265K | ﹤0.01% | 3817 |
|
|
2017
Q2 | – | Sell |
-799
| Closed | -$4K | – | 6700 |
|
|
2017
Q1 | $4K | Buy |
799
+699
| +699% | +$3.17K | ﹤0.01% | 4811 |
|
|
2016
Q4 | $0 | Sell |
100
-307
| -75% | -$1.42K | ﹤0.01% | 6430 |
|
|
2016
Q3 | $2K | Buy |
+407
| New | +$6.74K | ﹤0.01% | 5029 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$16 | – | 6376 |
|
|
2016
Q1 | $0 | Sell |
1
-65
| -98% | -$841 | ﹤0.01% | 6145 |
|
|
2015
Q4 | $0 | Buy |
+66
| New | +$873 | ﹤0.01% | 6045 |
|
|
2015
Q3 | – | Sell |
-132
| Closed | -$1K | – | 6101 |
|
|
2015
Q2 | $1K | Buy |
132
+111
| +529% | +$1.52K | ﹤0.01% | 4775 |
|
|
2015
Q1 | $0 | Buy |
+21
| New | +$283 | ﹤0.01% | 5504 |
|
Other funds holding FLNA
VCM
GC
Simplex Trading's FLNA Position: Q1 2026 in Review
Simplex Trading reduced its Filana Therapeutics (FLNA) stake by 19% in Q1 2026, selling an estimated $68.1K and leaving 139,995 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #4095.
Simplex Trading first reported a position in FLNA in Q1 2015 and has held it in 29 quarters since. The position peaked at $5.05M in Q3 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Simplex Trading held 139,995 shares of Filana Therapeutics worth $237K as of Q1 2026.
- Simplex Trading sold 33,070 Filana Therapeutics shares in Q1 2026, an estimated $68.1K.
- Filana Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4095 holding.
- Simplex Trading first reported a position in Filana Therapeutics in Q1 2015 and has held it in 29 quarters since.
- Simplex Trading's Filana Therapeutics position peaked at $5.05M in Q3 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.